These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22279181)

  • 1. Acute necrotizing pancreatitis related to tigecycline.
    Mascarello M; Papa G; Arnez ZM; Luzzati R
    J Antimicrob Chemother; 2012 May; 67(5):1296-7. PubMed ID: 22279181
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatric acute pancreatitis related to tigecycline.
    Prot-Labarthe S; Youdaren R; Benkerrou M; Basmaci R; Lorrot M
    Pediatr Infect Dis J; 2010 Sep; 29(9):890-1. PubMed ID: 20720475
    [No Abstract]   [Full Text] [Related]  

  • 3. Tigecycline-induced acute pancreatitis: case report and literature review.
    Hung WY; Kogelman L; Volpe G; Iafrati M; Davidson L
    Int J Antimicrob Agents; 2009 Nov; 34(5):486-9. PubMed ID: 19540093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tigecycline: a single antibiotic for polymicrobial infections.
    Pankey GA; Steele RW
    Pediatr Infect Dis J; 2007 Jan; 26(1):77-8. PubMed ID: 17195711
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute pancreatitis related to tigecycline: case report and review of the literature.
    Gilson M; Moachon L; Jeanne L; Dumaine V; Eyrolle L; Morand P; Ben m'Rad M; Salmon D
    Scand J Infect Dis; 2008; 40(8):681-3. PubMed ID: 18979610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute necrotizing pancreatitis: can tigecycline be included in a therapeutic strategy?
    Occhionorelli S; Morganti L; Cultrera R; Andreotti D; Maccatrozzo S; Cappellari L; Stano R; Vasquez G
    G Chir; 2015; 36(1):15-20. PubMed ID: 25827664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More about the safety of tigecycline for the treatment of infectious diseases: the role of superinfection rates.
    Martín-Gandul C; García-Cabrera E; Castillo-Ojeda E; Jiménez-Mejías ME
    J Antimicrob Chemother; 2012 Apr; 67(4):1048-9. PubMed ID: 22207597
    [No Abstract]   [Full Text] [Related]  

  • 8. True incidence of tigecycline-induced pancreatitis: how many cases are we missing?
    Davido B; Shourick J; Makhloufi S; Dinh A; Salomon J
    J Antimicrob Chemother; 2016 Oct; 71(10):2994-5. PubMed ID: 27365188
    [No Abstract]   [Full Text] [Related]  

  • 9. Extreme alkaline phosphatase elevation associated with tigecycline.
    Bonilla MF; Avery RK; Rehm SJ; Neuner EA; Isada CM; van Duin D
    J Antimicrob Chemother; 2011 Apr; 66(4):952-3. PubMed ID: 21393193
    [No Abstract]   [Full Text] [Related]  

  • 10. Tigecycline-induced pancreatitis.
    Lipshitz J; Kruh J; Cheung P; Cassagnol M
    J Clin Gastroenterol; 2009 Jan; 43(1):93. PubMed ID: 18769361
    [No Abstract]   [Full Text] [Related]  

  • 11. Tigecycline-induced acute pancreatitis in a cystic fibrosis patient: A case report and literature review.
    Hemphill MT; Jones KR
    J Cyst Fibros; 2016 Jan; 15(1):e9-11. PubMed ID: 26282838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose tigecycline-associated alterations in coagulation parameters in critically ill patients with severe infections.
    Routsi C; Kokkoris S; Douka E; Ekonomidou F; Karaiskos I; Giamarellou H
    Int J Antimicrob Agents; 2015 Jan; 45(1):90-3. PubMed ID: 25241261
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial commentary: Asking the right questions: morbidity, mortality, and measuring what's important in unbiased evaluations of antimicrobials.
    Powers JH
    Clin Infect Dis; 2012 Jun; 54(12):1710-3. PubMed ID: 22467671
    [No Abstract]   [Full Text] [Related]  

  • 14. Pancreatitis in tigecycline Phase 3 and 4 clinical studies.
    McGovern PC; Wible M; Korth-Bradley JM; Quintana A
    J Antimicrob Chemother; 2014 Mar; 69(3):773-8. PubMed ID: 24216769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, pharmacodynamics, safety and tolerability of tigecycline.
    Rello J
    J Chemother; 2005 Aug; 17 Suppl 1():12-22. PubMed ID: 16285354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of minocycline and tigecycline in a hamster model of leptospirosis.
    Tully CC; Hinkle MK; McCall S; Griffith ME; Murray CK; Hospenthal DR
    Diagn Microbiol Infect Dis; 2011 Dec; 71(4):366-9. PubMed ID: 22018938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing the role of tigecycline in an era of antimicrobial resistance.
    Schafer JJ; Goff DA
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):557-67. PubMed ID: 18847395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tigecycline-induced acute pancreatitis: about two cases and review of the literature.
    Marot JC; Jonckheere S; Munyentwali H; Belkhir L; Vandercam B; Yombi JC
    Acta Clin Belg; 2012; 67(3):229-32. PubMed ID: 22897076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute pancreatitis in ICU secondary to treatment with tigecycline.
    Bernas Albeniz A; Aveiga Valencia DA; Etxeberria Zabala L; Zaldibar-Gerrikagoitia Bilbao J; Aguilera Celorrio L
    Rev Esp Anestesiol Reanim; 2017 Jan; 64(1):46-49. PubMed ID: 27609674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure-response analyses of tigecycline tolerability in healthy subjects.
    Passarell J; Ludwig E; Liolios K; Meagher AK; Grasela TH; Babinchak T; Ellis-Grosse EJ
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):123-9. PubMed ID: 19748422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.